Your browser doesn't support javascript.
loading
Comparative diagnostic accuracy between simplified and original flow cytometric gating strategies for peripheral blood neutrophil myeloperoxidase expression in ruling out myelodysplastic syndromes.
Raskovalova, Tatiana; Scheffen, Laura; Jacob, Marie-Christine; Vettier, Claire; Bulabois, Bénédicte; Szymanski, Gautier; Chevalier, Simon; Gonnet, Nicolas; Park, Sophie; Labarère, José.
Afiliação
  • Raskovalova T; Institute for Advanced Biosciences, INSERM U1209, CNRS UMR 5309, Université Grenoble Alpes, Grenoble, France.
  • Scheffen L; Laboratoire d'Immunologie, Grenoble University Hospital, Grenoble, France.
  • Jacob MC; Institute for Advanced Biosciences, INSERM U1209, CNRS UMR 5309, Université Grenoble Alpes, Grenoble, France.
  • Vettier C; Institute for Advanced Biosciences, INSERM U1209, CNRS UMR 5309, Université Grenoble Alpes, Grenoble, France.
  • Bulabois B; Laboratoire d'Immunologie, Grenoble University Hospital, Grenoble, France.
  • Szymanski G; Laboratoire d'Hématologie Biologique, Grenoble University Hospital, Grenoble, France.
  • Chevalier S; Laboratoire d'Hématologie Biologique, Grenoble University Hospital, Grenoble, France.
  • Gonnet N; Laboratoire d'Hématologie Biologique, Grenoble University Hospital, Grenoble, France.
  • Park S; Laboratoire d'Hématologie Biologique, Grenoble University Hospital, Grenoble, France.
  • Labarère J; CIC 1406, INSERM, Université Grenoble Alpes, Grenoble University Hospital, Grenoble, France.
PLoS One ; 17(11): e0276095, 2022.
Article em En | MEDLINE | ID: mdl-36399441
BACKGROUND: Flow cytometric analysis of peripheral blood neutrophil myeloperoxidase expression is accurate in ruling out myelodyplastic syndromes (MDS) but might not be suitable for implementation in busy clinical laboratories. We aimed to simplify the original gating strategy and examine its accuracy. METHODS: Using the individual data from 62 consecutive participants enrolled in a prospective validation study, we assessed the agreement in intra-individual robust coefficient of variation (RCV) of peripheral blood neutrophil myeloperoxidase expression and compared diagnostic accuracy between the simplified and original gating strategies. RESULTS: Cytomorphological evaluation of bone marrow aspirate confirmed MDS in 23 patients (prevalence, 37%), unconfirmed MDS in 32 patients (52%), and was uninterpretable in 7 patients (11%). Median intra-individual RCV for simplified and original gating strategies were 30.7% (range, 24.7-54.4) and 30.6% (range, 24.7-54.1), with intra-class correlation coefficient quantifying absolute agreement equal to 1.00 (95% confidence interval [CI], 0.99 to 1.00). The areas under the receiver operating characteristic (ROC) curves were 0.93 (95% CI, 0.82-0.98) and 0.92 (95% CI, 0.82-0.98), respectively (P = .32). Using simplified or original gating strategy, intra-individual RCV values lower than a pre-specified threshold of 30.0% ruled out MDS for 35% (19 of 55) patients, with both sensitivity and negative predictive value estimates of 100%. CONCLUSIONS: The simplified gating strategy performs as well as the original one for ruling out MDS and has the potential to save time and reduce resource utilization. Yet, prospective validation of the simplified gating strategy is warranted before its adoption in routine. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03363399 (First posted on December 6, 2017).
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Peroxidase Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Peroxidase Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França País de publicação: Estados Unidos